Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
psychological sexual dysfunctions
MeSH D020018 - psychological sexual dysfunctions
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001523:
Mental disorders
0 Companies
0 Drugs
Success rate
D020018:
Psychological sexual dysfunctions
1 Company
1 Drug
$
Success rate
D000068116:
Gender dysphoria
0 Companies
0 Drugs
Success rate
D004414:
Dyspareunia
5 Companies
2 Drugs
$
Success rate
D007172:
Erectile dysfunction
25 Companies
6 Drugs
$
Success rate
D019968:
Sexual and gender disorders
2 Companies
1 Drug
$
Success rate
D052065:
Vaginismus
0 Companies
0 Drugs
Success rate
D061686:
Premature ejaculation
1 Company
2 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Warner Chilcott
Testosterone
Intrinsa
2006-07-28
Testosterone
Livensa
2006-07-28
Clinical Trials
Historical Success Rate
Phase 1
67
%
2/3
Phase 2
40
%
2/5
Phase 3
60
%
3/5
Approved:
0
Overall Success rate:
16%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Warner Chilcott
Testosterone
,
Testosterone enanthate
,
Testosterone undecanoate
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use